TRANSGENE

Euronext Paris
FR0005175080 - Stock

CAC 40 0.45% SBF 120 0.43% EUR / USD 0.16% EUR / GBP 0.42%

0.618
Last traded price
25/04/2025 - 17:29  CET
Since Open
+0.008 (+1.31%)
Since Previous Close
+0.006 (+0.98%)
Valuation Close
0.618
25/04/2025 - 17:55  CET
Best Bid 0.606
Best Ask 0.618
25/04/2025 - 17:40  CET

ESG ACHIEVEMENTS AND GOALS

Transgene is committed to a social responsibility policy guided by ethical behavior and values shared by all of the Company’s employees.

Bringing new therapeutic responses to cancer patients is Transgene’s mission. Through scientific and technological innovation, Transgene is working to push back the limits of existing treatments. Beyond the positive contribution of its drug candidates, Transgene wants to ensure the Company’s sustainability by creating value, strengthening its social contribution and minimizing its environmental impact.

Transgene’s ESG strategy is based on six commitments: commitment to patients, to our partners,  to our employees, to our shareholders and investors, to society and the regions, and the planet.

Transgene has not been required to publish a statement of non-financial performance (SNFP) – the Company has fewer than 500 employees – but has voluntarily continued its ESG reporting since then.

The importance of the ESG policy is based on the commitment of each employee and manager to this vision, and the need for the Company to attract and retain talent, to meet the expectations of investors.

This is why Transgene decided to adopt an ESG policy in 2020 to strengthen the alignment of its actions with sustainable development objectives.

ESG RATINGS

ESG Rating Agency Rating Date
Ethifinance 85 15/09/2023

ENVIRONMENTAL INDICATORS

Indicator Unit 2024 2023 2022
Scope 1 GHG emissions (CO2 eq) Ton 19 0
Scope 2 GHG emissions (CO2 eq) Ton 97 187
Scope 1 + 2 GHG emissions (CO2 eq) Ton 116 114 187
Scope 3 GHG emissions (CO2 eq) Ton 2,267
Total GHG emissions (CO2 eq) Ton 2,381
Carbon footprint (total GHG emissions / enterprise value) Ton / Million (EUR) 15.32
GHG intensity (total GHG emissions / revenue) Ton / Million (EUR) 311.89
Total energy consumption kWh 2,843,070 2,806,256 3,277,837
Share of non-renewable energy consumption and production % 50 50 50
Energy intensity (total energy consumption / revenue) MWh / Million (EUR) 467.53 367.6 327.72
Ratio of non-recycled waste % 7
Total water consumption cubic meter 2,759 2,113 4,771
Water consumption ratio (Volume / Revenue) cubic meter / Million (EUR) 453.71 276.79 477

SOCIAL & GOVERNANCE INDICATORS

Indicator Unit 2024 2023 2022
Headcount at year-end unit 165 158 168
Share of women in total workforce % 62.4 62.7 63.1
Share of women in management bodies % 44.4 37.5 25
Professional equality index unit 99 95 92
Rate of employees with disabilities % 3 4.4 3
Rate of absenteeism % 5.4 3 4.2
Average training hours per employee unit 18.4 17.2 17
Board gender diversity (female board members / total board members) % 40 44.4 40
Number of board members unit 10 9 10
Number of female board members unit 4 4 4
Board independence rate % 40 44.4 50

FINANCIAL INDICATORS

Indicator Unit 2024 2023 2022
Annual revenue Thousand (EUR) 6,081 7,634 10,002
Enterprise value at fiscal year-end Thousand (EUR) 100,356 155,463 179,657
Taxonomy-eligible turnover % 0 0 0
Taxonomy-aligned turnover % 0 0 0
Taxonomy-eligible CapEx % 1 12 5
Taxonomy-aligned Capex % 1 12
Taxonomy-eligible OpEx % 0 0 0
Taxonomy-aligned OpEx % 0 0 0

ESG CONTACT PERSON

Lucie Larguier
VP Corporate Communication and Investor Relations

larguier@transgene.fr